
MOLECULAR PARTNERS AG
MOLECULAR PARTNERS AG (MOLN)
WebsitePrice
Market cap
Next catalystDec 5, 2026MP0712 — US Phase 1/2a study · Phase 1/2 dataCompany release ↗
Cash
Chart & Events
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
History / paused
Financial position
Upcoming milestones
Financial history
Annual trends
| Reported item | |||||
|---|---|---|---|---|---|
Reported shares and borrowings
Ownership and institutions
| Status | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|